Clinical Trial Update: A Safety Study of XL019 in Adults With Myelofibrosis [Phase 1]

View source ↗

Summary

This clinical trial update reports termination of a Phase 1 safety study of XL019 in adults with myelofibrosis and related myeloproliferative disorders conducte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• XL019

Snippet

Sponsor: Exelixis | Conditions: Myeloproliferative Disorders, Myelofibrosis | Phase 1 | Status: TERMINATED